Literature DB >> 10467954

Characterization of the carrier-mediated transport of levofloxacin, a fluoroquinolone antimicrobial agent, in rabbit cornea.

K Kawazu1, Y Midori, H Shiono, A Ota.   

Abstract

The cornea presents a formidable barrier to drug penetration. The fluoroquinolone levofloxacin, which is an effective antimicrobial agent, has the potential to be used in the topical treatment of ocular disease. Thus, we sought to characterize how levofloxacin penetrates the cornea. To perform this characterization, we measured the time dependent permeation of levofloxacin across the isolated rabbit cornea using a diffusion chamber, and compared it with antipyrine fluxes. Levofloxacin permeation into the receiver epithelial-side bathing solution (pH = 6.5) from the donor endothelial-side (pH = 7.4) reached 3.00 nmolcm(-2) cornea after 2h, whereas in the opposite direction permeation was 1.89 nmolcm(-2) cornea. Based on the temperature-dependent effects on permeation, the calculated energy of activation for permeation, Ea, was 31.3 kcal mol(-1), whereas Ea for antipyrine, a marker of diffusion, was 11.0 kcalmol(-1). The transport of levofloxacin from epithelium to endothelium was concentration-dependent and had both a linear and saturable component. Evaluation of the kinetic parameters, Jmax, apparent Km and k(d) showed that they were 38.78 pmol min(-1) cm(-2), 3.83 mM and 0.0135 microL min(-1) cm(-2), respectively. These results, coupled with the fact that levofloxacin permeation reached a maximum value at pH 6.5, suggest that levofloxacin transport across the cornea is carrier mediated. However, at present, it cannot be ascertained whether such a system is localized in either the corneal epithelial or the endothelial layer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467954     DOI: 10.1211/0022357991773168

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

Review 1.  Comparative review of topical ophthalmic antibacterial preparations.

Authors:  P Y Robert; J P Adenis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

3.  Penetration of fluorescein across the rabbit cornea from the endothelial surface.

Authors:  Chhavi Gupta; Anuj Chauhan; Sangly P Srinivas
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

4.  Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.

Authors:  Pravin Kondiba Pawar; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2006-02-10       Impact factor: 3.246

Review 5.  Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

6.  Effect of in vitro transcorneal approach of aceclofenac eye drops through excised goat, sheep, and buffalo corneas.

Authors:  Vivek Dave; Sarvesh Paliwal; Sachdev Yadav; Swapnil Sharma
Journal:  ScientificWorldJournal       Date:  2015-01-13

7.  Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops.

Authors:  Biswaranjan Mohanty; Sagar Kumar Mishra; Dipak K Majumdar
Journal:  J Adv Pharm Technol Res       Date:  2013-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.